Evolving immunotherapeutic strategies in bladder and renal cancer

For patients with urological cancers, immunotherapy is currently a treatment option for metastatic renal cell carcinoma, and those with high risk'' superficial bladder cancers. In this review, our current understanding of tumour immune escape is discussed. The principles and role of current immunotherapies for these tumours are described, and new areas of immunotherapeutic promise are highlighted.